Loading the section…
Up to five U.S. securities side by side.
| Metric | CTKBCytek Biosciences, Inc. |
|---|---|
| Price | 6.13 |
| Change | −2.78 % |
| Return, 1 year | +30.60 % |
| Market capitalisation | 796M |
| Price / earnings | — |
| Price / sales | 3.9 |
| Price / book | 2.5 |
| Enterprise value / EBITDA | — |
| Return on equity | −25.03 % |
| Net margin | −38.98 % |
| Revenue, last year | 207M |
| Net income, last year | −81M |
| Revenue growth, year over year | +5.44 % |
| Debt / equity | — |
| Volatility, 30 days | 55.52 % |
| Beta | 0.84 |
| Sector | Health care |
Data: US exchange trading and company filings with the regulator